scispace - formally typeset
M

Mariah M Kalmin

Researcher at University of California, Los Angeles

Publications -  19
Citations -  356

Mariah M Kalmin is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Buprenorphine & Medicine. The author has an hindex of 6, co-authored 14 publications receiving 235 citations. Previous affiliations of Mariah M Kalmin include George Washington University & University of North Carolina at Chapel Hill.

Papers
More filters
Journal ArticleDOI

The effect of HIV infection on longitudinal lung function decline among IDUs: a prospective cohort.

TL;DR: In this article, the authors used longitudinal data from ALIVE to determine the independent association of HIV infection on lung function decline over almost three years of observations and hypothesized that HIV infection, particularly more advanced HIV disease, would be associated with accelerated lung function degradation.
Journal ArticleDOI

Development of a large urban longitudinal HIV clinical cohort using a web-based platform to merge electronically and manually abstracted data from disparate medical record systems: technical challenges and innovative solutions

TL;DR: To monitor and improve care of HIV-infected patients in Washington, DC, one of the most severely affected urban areas in the United States, a city-wide database across 13 clinical sites using electronic data abstraction and manual data entry from EMRs is developed.
Journal ArticleDOI

Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation.

TL;DR: While age and day 3 FSH levels were predictive of outcome, it is found no association between insLQ and patient response to COH, the first report suggesting that LHCGR genetic variation might function in patient risk for OHSS.
Journal ArticleDOI

Rapid Adoption of Low-Threshold Buprenorphine Treatment at California Emergency Departments Participating in the CA Bridge Program

TL;DR: In this paper, the authors retrospectively evaluated the implementation of low-threshold emergency department (ED) buprenorphine treatment at 52 hospitals participating in the CA Bridge Program using the Reach, effectiveness, adoption, implementation, maintenance.